Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2R9F

Calpain 1 proteolytic core inactivated by ZLAK-3002, an alpha-ketoamide

Summary for 2R9F
Entry DOI10.2210/pdb2r9f/pdb
Related1kxr 1tl9 1tlo 2R9C 2g8e 2g8j
DescriptorCalpain-1 catalytic subunit, CALCIUM ION, CHLORIDE ION, ... (6 entities in total)
Functional Keywordsprotease, peptidase, inhibitor, alpha-ketoamide, hydrolase, membrane, thiol protease
Biological sourceRattus norvegicus (Rat)
Cellular locationCytoplasm : P97571
Total number of polymer chains1
Total formula weight39694.93
Authors
Qian, J.,Campbell, R.L.,Davies, P.L. (deposition date: 2007-09-12, release date: 2008-08-26, Last modification date: 2023-08-30)
Primary citationQian, J.,Cuerrier, D.,Davies, P.L.,Li, Z.,Powers, J.C.,Campbell, R.L.
Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.
J.Med.Chem., 51:5264-5270, 2008
Cited by
PubMed Abstract: Calpains are intracellular cysteine proteases that catalyze the cleavage of target proteins in response to Ca(2+) signaling. When Ca(2+) homeostasis is disrupted, calpain overactivation causes unregulated proteolysis, which can contribute to diseases such as postischemic injury and cataract formation. Potent calpain inhibitors exist, but of these many cross-react with other cysteine proteases and will need modification to specifically target calpain. Here, we present crystal structures of rat calpain 1 protease core (muI-II) bound to two alpha-ketoamide-based calpain inhibitors containing adenyl and piperazyl primed-side extensions. An unexpected aromatic-stacking interaction is observed between the primed-side adenine moiety and the Trp298 side chain. This interaction increased the potency of the inhibitor toward muI-II and heterodimeric m-calpain. Moreover, stacking orients the adenine such that it can be used as a scaffold for designing novel primed-side address regions, which could be incorporated into future inhibitors to enhance their calpain specificity.
PubMed: 18702462
DOI: 10.1021/jm800045t
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon